P R CEMENTS LTD Q4 RESULTS
![Take notice! In a muted Q1 season, these 14 companies doubled sales and profits](https://img.etimg.com/thumb/msid-112823853,width-100,height-75,resizemode-4/markets/stocks/earnings/take-notice-in-a-muted-q1-season-these-14-companies-doubled-sales-and-profits.jpg)
Take notice! In a muted Q1 season, these 14 companies doubled sales and profits
14 companies with market capitalization exceeding Rs 2,500 crore demonstrated exceptional performance in Q1 2024, doubling their sales and profits. Top performers included Spright Agro and Diamond Power Infrastructure. The broader market saw mixed results with sectors like BFSI and automobile doing well, but oil marketing companies underperforming.
![Zomato captains India Inc’s dream Team XI with over 1,000% profit growth](https://img.etimg.com/thumb/msid-112793975,width-100,height-75,resizemode-4/markets/stocks/news/zomato-captains-india-incs-dream-team-xi-with-over-1000-profit-growth.jpg)
Zomato captains India Inc’s dream Team XI with over 1,000% profit growth
The June quarter saw Zomato and 10 other companies achieving over 1,000% profit growth. Zomato's profit skyrocketed 12,550% year-on-year. Other remarkable performers were Shakti Pumps and Lotus Chocolate. Experts advise focusing on growth outlooks rather than past profits when making investment decisions.
![Q1 results shocker: 40 companies report more than 50% drop in profit](https://img.etimg.com/thumb/msid-112727284,width-100,height-75,resizemode-4/markets/stocks/earnings/q1-results-shocker-40-companies-report-more-than-50-drop-in-profit.jpg)
Q1 results shocker: 40 companies report more than 50% drop in profit
The profits of 40 Indian companies have plummeted by more than 50% in the June quarter, primarily due to higher raw material costs and unfavorable base effects. Notable names like Allcargo Logistics and Rajesh Exports saw drastic declines. Analysts suggest cautious investment strategies amid high market valuations and slowing profit growth.
![Zydus Lifesciences Q1 results: Net profit jumps 31% to Rs 1420 crore](https://img.etimg.com/thumb/msid-112453433,width-100,height-75,resizemode-4/markets/stocks/earnings/zydus-lifesciences-q1-results-net-profit-jumps-31-to-rs-1420-crore.jpg)
Zydus Lifesciences Q1 results: Net profit jumps 31% to Rs 1420 crore
The earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 38.4% YoY to Rs 2084 crore. On QoQ, EBITDA increased 27.8%.
![Vodafone Idea Q1 preview: Subscriber losses, flat ARPU to dent revenue prospects](https://img.etimg.com/thumb/msid-112444874,width-100,height-75,resizemode-4/markets/stocks/earnings/vodafone-idea-q1-preview-subscriber-losses-flat-arpu-to-dent-revenue-prospects.jpg)
Vodafone Idea Q1 preview: Subscriber losses, flat ARPU to dent revenue prospects
Vodafone Idea is expected to report a flat revenue for the quarter that ended June 30 owing to losses in the subscriber base coupled with a flattish Average Revenue Per User (ARPU) according to estimates by four brokerages.
![Alkem Labs Q1 Results: Net profit zooms 90% to Rs 545 crore](https://img.etimg.com/thumb/msid-112407835,width-100,height-75,resizemode-4/markets/stocks/earnings/alkem-labs-q1-results-net-profit-zooms-90-to-rs-545-crore.jpg)
Alkem Labs Q1 Results: Net profit zooms 90% to Rs 545 crore
The company reported Rs 287 crore in the corresponding quarter of the previous year. Revenue from operations grew 2.2% y-o-y to Rs 3032 crore in Q1FY25.
- Go To Page 1
Grasim Industries Q1 Results: Profit slides by a fourth to Rs 1,189 crore on investment in paints ops
The flagship company of the Aditya Birla launched its paints operations ‘Birla Opus’ towards the end of the March quarter, and April-June was its first quarter of full operations. The company has spent Rs 7,795 crore on its paints business as of June-end, approximately four-fifth of the total planned expenditure for these operations.
Biocon Q1 Results: Net Jumps 6-fold to Rs 660 cr on one-time gain
Biocon's net profit for Q1FY25 surged to ₹660 crore, up from ₹101 crore the previous year, primarily due to a one-time gain from selling Biocon Biologics' domestic branded formulation business. Revenue remained flat at ₹3,433 crore. Core EBITDA saw a decline, although overall EBITDA improved significantly due to the one-off gain.
Shree Cement shares drop over 3% after 51% YoY decline in Q1 PAT. Should you invest?
Shree Cement faced a 4% drop in shares as it posted a 51% decrease in net profit for the June quarter, down to Rs 278.6 crore. Revenues saw a slight increase to Rs 5,123.9 crore, but higher expenses offset gains. Brokerages had varied opinions, noting concerns about weak demand and geographic expansion.
Shree Cement Q1 Results: PAT declines 51% YoY to Rs 278 crore; revenue rises marginally
Shree Cement Q1 Results: During the first quarter of the 2025 fiscal year, the company reported a 1.75% increase in revenue from operations, reaching Rs 5,123.9 crore compared to Rs 5,035.6 crore in the same period last year. Total expenses also rose by 4.4% to Rs 4,618 crore from Rs 4,422 crore in the first quarter of the previous fiscal year. Despite these figures, the company's stock price experienced a slight decline of 0.2% to Rs 26,682 following the release of the earnings report.
Ambuja Cements Q1 Results: Standalone profit falls 12% YoY to Rs 571 crore, revenue drops 5%
Ambuja Cements saw an 11.5% drop in standalone profit to Rs 571 crore for the June quarter. Revenue decreased 4.5% to Rs 4,516 crore. Operating EBITDA fell to Rs 646 crore, and EBITDA margin dropped to 14.3%. Sales volume grew by 3%, and kiln fuel costs were reduced by 17%. CEO Ajay Kapur emphasized cost-cutting initiatives.
GIFT Nifty signals a muted start for D-Street. Here's the trading setup for today's session
Markets remain steady before Union Budget with anticipated volatility. Oil prices decline for third consecutive day due to oversupply worries and subdued demand. Rupee hits record low against US dollar as Asian currencies weaken. Keep an eye on Q1 results from major firms.
Sensex falls over 300 pts as RIL & bank stocks tumble, Nifty below 24,400
Ahead of the budget, Indian markets fell. Sensex dropped 355 points, Nifty50 by 148 points. Reliance fell 2.5% from lower fuel margins; HDFC Bank, the country's top private lender, rose 1% after beating profit forecasts; Wipro dropped 8% due to weak demand in Europe and Asia-Pacific. Mixed performance among key stocks in early trading.
Q1 Results Today: What to expect from HDFC Bank and Kotak Bank’s earnings
HDFC Bank's Q1 FY25 financial results are likely to be less impressive than the previous quarter, primarily due to slower deposit growth. The merger with HDFC Ltd. makes year-over-year comparisons irrelevant. Loan growth is also expected to moderate, impacting net interest income. While the bank navigates the challenges of integration and a tougher economic environment, its profitability might see a minor dip in this quarter.
UltraTech Cement Q1 Results: Cons PAT rises marginally to Rs 1,697 crore, revenue up 2% YoY
The revenue from operations stood at Rs 18,070 crore, which represents a 2% increase compared to Rs 17,737 crore reported by the company in the corresponding quarter of the last financial year. On a sequential basis, the cons PAT was down by 25% over Rs 2,258 crore reported by the cement maker in Q4FY24.
Grasim Q4 revenue at record Rs 37,727 crore
While operating profit of the flagship company of the Aditya Birla Group jumped by a little over a fourth to ₹6,196 crore during the quarter, also an all-time high, the net profit remained flat on year at ₹1,370 crore. Adjusted for an exceptional item charge of ₹538 crore, the bottomline rose by two-fifths on year.
Sun Pharma net profit jumps 34% YoY to Rs 2,654.6 crore in Q4FY24
Sun Pharma's Q4FY24 net profit rises 34% YoY to Rs 2654.6 crore, driven by increased sales of global specialty products. Interim dividend of Rs. 5 declared for FY24.
Eris Lifesciences Q4 Results: Net profit jumps over 29% to Rs 80 crore
The Ahmedabad-based drug maker reported a net profit of Rs 61.5 crore during the corresponding quarter of the previous year. Revenue of Q4FY 24 grew by 37% YoY to Rs 551 crore. The net debt on March 31 stood at Rs 2700 crore.
India Cements Q4 Results: Net loss narrows to Rs 50.06 crore
The cement and clinker volume for the fourth quarter was 24.36 lakh tonne as compared to 27.85 lakh tonne in the same period of the previous year, it added.
Biocon Q4 Results: Net profit drops 57% to Rs 136 crore
Total revenue grew 1% YoY to Rs 3,966 crore. EBITDA for the quarter declined 16% YoY to Rs 964 crore, representing an EBITDA margin of 24% versus 29% in the same period last year. The gross R&D spends declined 36% YoY to Rs 228 crore in Q4FY24.
Shree Cement Q4 Results: Net profit up over a fifth to Rs 662 crore, EBITDA at all-time high
The country’s third-largest producer of cement, in terms of capacity, saw its net revenue from operations rise 7% on year to Rs 5,101 crore. The relatively lower growth in revenue as compared to the sales growth indicates that the company, too, felt the impact of weaker pricing.
Shree Cement Q4 Results: PAT jumps 28% YoY to Rs 526 crore; Rs 55/sh dividend declared
On Tuesday, Shree Cement announced a significant 28% year-on-year increase in its consolidated net profit, reaching Rs 675 crore for the quarter ending March 31, 2024, compared to Rs 526 crore reported in the same period last fiscal year.
Q4 results today: Bharti Airtel, Patanjali Foods among 97 companies to announce earnings on Tuesday
Bharti Airtel and 96 other companies are set to announce Q4 results. Airtel's expected net profit ranges from Rs 2,201-5,309 crore with revenue projections of Rs 38,736-39,360 crore.
Ambuja Cements Q4 Results: Profit doubles to to Rs 1,526 crore on volume growth, cost optimization
Ambuja Cements’ consolidated net profit for the March quarter nearly doubled on year to Rs 1,526 crore aided by a robust volume growth and cost reduction.
Ambuja Cements Q4 results: Profit up 6% YoY to Rs 532 cr; co approves Rs 2 dividend
Ambuja Cements reported a standalone net profit of 532 crore rupees for the quarter that ended in March 2024, showing a 6% increase compared to the previous year. Revenue from operations in the fourth quarter rose by 12% year-on-year to Rs 4,780 crore. The Board has recommended a dividend of Rs 2 per equity share for the financial year 2023-24, subject to approval of shareholders of the company.
Q4 results today: Ambuja Cements, Adani Wilmar among 18 companies to announce earnings
Adani group leads Q4 earnings with multiple companies reporting results today. Ambuja Cements expected to show growth, while Adani Wilmar anticipates revenue dip but higher operating profit.
UltraTech to retain edge over competition amid cost efficiency, capacity addition
During an earnings call after the quarterly result announcement, the company's management stated that it would reduce the cost of production per tonne by Rs200-300 in the next three years by focussing on a series of initiatives such as increasing investments in green power, reducing lead distance by improving distribution channel, and improving clinker-cement conversion.
UltraTech Cement Q4 Results: Board approves dividend of Rs 70/share
The cement maker reported a Profit After Tax (PAT) of Rs 2,258 crore, up 36% YoY, beating the Street estimates of Rs 2,048 crore.
UltraTech Cement Q4 Results: Profit rises 36% YoY to Rs 2,258 crore, beats estimates
UltraTech Cement Q4 Results: UltraTech Cement's Q4 net profit surged 36% YoY to Rs 2,258 crore. Domestic sales reached 33.22 million tons of grey cement, with a total capacity of 140.8 MTPA and a 25.7% green power mix.
Load More